Top Biomed Stock Signal: EXAS
Report Date: 03-17-2024
Symbol: EXAS - Exact Sciences Corporation
Sector:
Industry:
Top Biomed Stock Signal: EXAS
Exact Sciences Corporation (EXAS)
441 Charmany Dr
Madison, WISCONSIN 53719
Phone: 16082845700
Website: http://www.exactsciences.com
CEO: Mr. Kevin Conroy
NASDAQ, Nasdaq Capital Market
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.